Literature DB >> 7621233

Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors.

D C Tang1, S A Johnston, D P Carbone.   

Abstract

Efficient introduction of biologically active genes into tumor cells in vivo would facilitate cancer gene therapy. In this study, recombinant adenoviruses mediated high-level expression of reporter genes in both human and murine tumor cell lines and freshly resected human solid tumors in vitro. When adenovirus vectors were inoculated intratumorally in a living animal, reporter activity was detected only in the tumor nodule and not in other sites, in contrast to intracardiac injections in which expression was found in several organs. Adenovirus-mediated gene expression was further enhanced by butyrate treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7621233

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  12 in total

1.  Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector.

Authors:  C Sarkis; C Serguera; S Petres; D Buchet; J L Ridet; L Edelman; J Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.

Authors:  Debadyuti Ghosh; Michael A Barry
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.

Authors:  Sang Young Ryu; Kidong Kim; Woo Sik Lee; Hee Chung Kwon; Kee Ho Lee; Chang Min Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

4.  A differential proteome in tumors suppressed by an adenovirus-based skin patch vaccine encoding human carcinoembryonic antigen.

Authors:  Chun-Ming Huang; Zhongkai Shi; Tivanka S DeSilva; Masato Yamamoto; Kent R Van Kampen; Craig A Elmets; De-chu C Tang
Journal:  Proteomics       Date:  2005-03       Impact factor: 3.984

5.  Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.

Authors:  Z Shi; M Zeng; G Yang; F Siegel; L J Cain; K R van Kampen; C A Elmets; D C Tang
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy.

Authors:  Z Hu; A Garen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 7.  Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.

Authors:  De-chu C Tang; Jianfeng Zhang; Haroldo Toro; Zhongkai Shi; Kent R Van Kampen
Journal:  Expert Rev Vaccines       Date:  2009-04       Impact factor: 5.217

8.  Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy.

Authors:  Sean E Hofherr; Julien S Senac; Christopher Y Chen; Donna J Palmer; Philip Ng; Michael A Barry
Journal:  Hum Gene Ther       Date:  2009-02       Impact factor: 5.695

9.  Optimization of transient gene expression in mammalian cells and potential for scale-up using flow electroporation.

Authors:  J H Parham; M A Iannone; L K Overton; J T Hutchins
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

10.  An Efficient Method for the Delivery of the Interleukin-2 Gene to Human Hematopoietic Cells using the 
Fiber-Modified Recombinant Adenovirus.

Authors:  V N Rogozhin; D Yu Logunov; D V Shchebliakov; M M Shmarov; E E Khodunova; I V Galtseva; R V Belousova; B S Naroditsky; A L Gintsburg
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.